Co-Diagnostics, Inc. (CODX) Free cash flow 2016–2025
Co-Diagnostics, Inc. (CODX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$29.8MFY2025 · since FY2016: -$1.3M → -$29.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.8M | +0.2% |
| FY2024 | -$29.9M | -27.5% |
| FY2023 | -$23.4M | -556.1% |
| FY2022 | $5.1M | -87.3% |
| FY2021 | $40.4M | +47.5% |
| FY2020 | $27.4M | +585.8% |
| FY2019 | -$5.6M | -36.8% |
| FY2018 | -$4.1M | -23.4% |
| FY2017 | -$3.3M | -152.2% |
| FY2016 | -$1.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice